BeiGene (BGNE) Tops Q3 EPS by 95c
Tweet
Share
E-mail
Get Alerts BGNE Hot Sheet
Join SI Premium – FREE
BeiGene (NASDAQ: BGNE) reported Q3 EPS of ($0.09), $0.95 better than the analyst estimate of ($1.04). Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $980.5 million.
For earnings history and earnings-related data on BeiGene (BGNE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump: nominate Heidi Overton, MD, PhD, as our next FDA commissioner
- Lowe's slashes full-year sales outlook amid DIY spending pressure
- Lyntris opens at $15.50, below IPO price of $17.50
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
